Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues
about
Nitrile-containing pharmaceuticals: efficacious roles of the nitrile pharmacophoreStructural basis for the inhibitory efficacy of efavirenz (DMP-266), MSC194 and PNU142721 towards the HIV-1 RT K103N mutantCrystal engineering of HIV-1 reverse transcriptase for structure-based drug designSearch for non-nucleoside inhibitors of HIV-1 reverse transcriptase using chemical similarity, molecular docking, and MM-GB/SA scoringScreening for NNRTIs with slow dissociation and high affinity for a panel of HIV-1 RT variants.New anti-HIV agents and targets.The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.An overview of phenylcyclopropylamine derivatives: biochemical and biological significance and recent developments.Conformational restriction: an effective tactic in 'follow-on'-based drug discovery.N-Pyrrylarylsulfones with High Therapeutic Potential.Mechanistic Study of Common Non-Nucleoside Reverse Transcriptase Inhibitor-Resistant Mutations with K103N and Y181C SubstitutionsNovel fluorine-containing DAPY derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2014072419.Positional adaptability in the design of mutation-resistant nonnucleoside HIV-1 reverse transcriptase inhibitors: a supramolecular perspective.
P2860
Q24569706-685F505C-BDF9-4F9A-9C45-41974B61BF5FQ27638329-93348DDF-7C17-403F-B3D5-AE52DF1CAF65Q27651402-4E6787E4-4521-4E9E-B719-3443F364ED7AQ33303221-5F638AF2-0590-47FD-9B2C-6C6D27E59049Q33436601-3D99C444-3C74-441B-A7FF-FE1B55FF0C1EQ34944447-51EF39AE-941C-4866-8947-4DE20D05E796Q35123663-55DE67C8-909F-45A7-A281-A159CD9A9392Q38034731-F347F8CB-7E90-43AD-BF73-DCCF93AA8B67Q38223014-A13C527D-9CC9-4453-9197-9483574D14F2Q39173240-B57BC559-4D78-4A71-8F7A-2030383860C2Q39350740-9086F744-82D3-4577-98FB-4B0F6C581531Q40977182-E8E5A99F-B347-410F-9685-2A0880C94517Q42042678-33F80BB7-B355-4179-B9B5-7196C303C653
P2860
Urea-PETT compounds as a new class of HIV-1 reverse transcriptase inhibitors. 3. Synthesis and further structure-activity relationship studies of PETT analogues
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Urea-PETT compounds as a new c ...... ship studies of PETT analogues
@ast
Urea-PETT compounds as a new c ...... ship studies of PETT analogues
@en
Urea-PETT compounds as a new c ...... ship studies of PETT analogues
@nl
type
label
Urea-PETT compounds as a new c ...... ship studies of PETT analogues
@ast
Urea-PETT compounds as a new c ...... ship studies of PETT analogues
@en
Urea-PETT compounds as a new c ...... ship studies of PETT analogues
@nl
prefLabel
Urea-PETT compounds as a new c ...... ship studies of PETT analogues
@ast
Urea-PETT compounds as a new c ...... ship studies of PETT analogues
@en
Urea-PETT compounds as a new c ...... ship studies of PETT analogues
@nl
P2093
P3181
P356
P1476
Urea-PETT compounds as a new c ...... ship studies of PETT analogues
@en
P2093
B L Sahlberg
C Sahlberg
J Kangasmetsä
K Fridborg
N G Johansson
P304
P3181
P356
10.1021/JM990095J
P407
P577
1999-10-07T00:00:00Z